Entre las marcas de nuestros más de 25 colaboradores destaca TargetMol
We have reached an agreement with TargetMol: CymitQuimica clients will benefit for a 20% discount on all TargetMol products until the end of the year.On our website you can find the products offered by this partner, which has become one of the world's most recognised compound libraries and small molecule inhibitors supplier. TargetMol offers approximately 120 compound libraries and a wide range of chemical products and kits for life sciences.
Termina el 31 dic( quedan 8 días )
MtInhA-IN-1
MtInhA-IN-1: an oral selective MtInhA inhibitor, IC50 0.23 μM, effective against M. tuberculosis with MIC 0.4 μM.Fórmula:C21H22BrN3Forma y color:SolidPeso molecular:396.32TRK II-IN-1
CAS:<p>TRK II-IN-1: potent type II TRK inhibitor; IC50s: TRKA (3.3 nM), TRKB (6.4 nM), TRKC (4.3 nM), TRKA G667C (9.4 nM); also targets FLT3, RET, VEGFR2.</p>Fórmula:C29H31F3N8OPureza:98%Forma y color:SolidPeso molecular:564.6NLRP3-IN-12
NLRP3-IN-12 inhibits NLRP3 inflammasome, curbing IL-1β release with 0.45 μM IC50, for inflammatory bowel disease research.Fórmula:C27H32ClNO7Forma y color:SolidPeso molecular:518STAT3-IN-15
STAT3-IN-15: Potent, oral STAT3 inhibitor for IPF, blocks STAT3 phosphorylation, cell migration, and EMT.Fórmula:C20H17F3N2O3SForma y color:SolidPeso molecular:422.42hCA IX-IN-2
hCA IX-IN-2 is a highly potent and selective inhibitor of hCA IX, exhibiting an inhibition constant (K I) value of 32.1 nM and demonstrating anti-proliferativeFórmula:C23H24N2O4STeForma y color:SolidPeso molecular:552.11HSP90-IN-18
HSP90-IN-18 inhibits Hsp90 with 0.39 μM IC50, useful for viral, neurodegenerative, and inflammatory research.Fórmula:C25H33FO3Forma y color:SolidPeso molecular:400.53HSP90-IN-19
CAS:HSP90-IN-19: potent Hsp90 inhibitor, IC50 = 0.27 μM, used in research on viral diseases, neurodegeneration, inflammation.Fórmula:C29H38O7Pureza:98%Forma y color:SolidPeso molecular:498.61CYP1B1-IN-3
CAS:CYP1B1-IN-3: strong CYP1B1 inhibitor (IC50: 6.6 nM); weak on CYP1A1/CYP1A2; hinders cell migration, invasion; blocks P-gp, AKT/ERK, FAK/SRC, EMT.Fórmula:C20H16FN3O2S2Forma y color:SolidPeso molecular:413.49DNQX
CAS:<p>DNQX (FG 9041) is a competitive, non-NMDA glutamate receptor antagonist (IC50s = 0.5 and 0.1 μM for AMPA and kainate receptors, respectively)</p>Fórmula:C8H4N4O6Pureza:97.27% - 99.1%Forma y color:Off-White Powder With A Yellow TingePeso molecular:252.14CYP1B1-IN-4
CAS:<p>CYP1B1-IN-4: 2,4-diarylthiazole, selective CYP1B1 inhibitor (IC50=0.2 nM), low cytotoxicity, stable in liver microsomes.</p>Fórmula:C18H14N2O2SPureza:98.74%Forma y color:SolidPeso molecular:322.38CYP1B1-IN-5
CAS:CYP1B1-IN-5: selective CYP1B1 inhibitor, IC50 = 4.7 nM, useful for metabolism disease research.Fórmula:C14H8INO2Pureza:97.66%Forma y color:SolidPeso molecular:349.12HDAC6-IN-15
HDAC6-IN-15: selective HDAC6 inhibitor, IC50 of 38.2 nM, for cancer and neurodegenerative research.Fórmula:C25H28FFeN3O2Forma y color:SolidPeso molecular:477.35Urease-IN-4
<p>Urease-IN-4 inhibits urease (IC50: 1.64 µM), targets P. vulgaris (IC50: 15.27 µg/mL), and is low in cytotoxicity.</p>Fórmula:C16H20N2O3SForma y color:SolidPeso molecular:320.41Urease-IN-5
Urease-IN-5: urease inhibitor, IC50 1.473 µM, low cytotoxicity, IC50 17.78 µg/mL on P. vulgaris.Fórmula:C16H20N2O3SForma y color:SolidPeso molecular:320.41JQEZ5
CAS:JQEZ5 is an inhibitor of EZH2 lysine methyltransferase (IC50 = 11.1 nM).Fórmula:C30H38N8O2Pureza:98.14% - ≥98%Forma y color:SolidPeso molecular:542.68KIF18A-IN-7
CAS:KIF18A-IN-7 is an orally active inhibitor targeting KIF18A, demonstrating potent inhibition with an IC50 value of 9.4 nM against the microtubule-dependentFórmula:C27H35N3O5S2Forma y color:SoildPeso molecular:545.71Leritrelvir
CAS:<p>Dermatan sulphate sodium (Chondroitin sulfate B sodium salt) is a linear sulfated polysaccharide, a glycosaminoglycan component of important proteoglycans.</p>Fórmula:C31H44F3N5O6Pureza:97.42%Forma y color:SolidPeso molecular:639.71Pomotrelvir
CAS:<p>Pomotrelvir (PBI-0451) is an oral SARS-CoV-2 3CL protease inhibitor with antiviral properties for COVID-19 research.</p>Fórmula:C23H26ClN5O3Forma y color:SolidPeso molecular:455.94BAY 2965501
CAS:BAY 2965501 is a potent and selective diacylglycerol kinase zeta (DGKζ) inhibitor that induces pERK activation.BAY 2965501 can be used in the study of cancer.Fórmula:C20H19FN4O3SPureza:99.89%Forma y color:SolidPeso molecular:414.45Moiramide B
CAS:Moiramide B is an acetyl coenzyme A carboxylase inhibitor with antimicrobial activity, strongly inhibiting Gram-positive bacteria.Fórmula:C25H31N3O5Pureza:98.53% - 99.90%Forma y color:SolidPeso molecular:453.53(S)-VQW-765
(S)-VQW-765, oral α7 nAChR partial agonist, may improve cognition in Alzheimer's and schizophrenia.Fórmula:C19H22N2OForma y color:SolidPeso molecular:294.39Tiludronate
CAS:Tiludronate, an oral bisphosphonate, treats metabolic bone disorders and inhibits osteoclasts.Fórmula:C7H9ClO6P2SForma y color:SolidPeso molecular:318.61Cloxacillin
CAS:Cloxacillin, a β-lactamase inhibitor, tackles S. aureus inflammation and has an IC50 of 0.04 µM.Fórmula:C19H18ClN3O5SForma y color:SolidPeso molecular:435.88Acamprosate
CAS:Acamprosate, alcohol dependence treatment. Affordable Excellence: Reliable Quality You Can TrustFórmula:C5H11NO4SPureza:98.30%Forma y color:SolidPeso molecular:181.21Valorphin
CAS:Valorphin (Valorphin TFAsalt) has opioid analgesic activity, binds to rat mu-opioid receptor, with an IC50 of 14 nM.Fórmula:C44H61N9O11Pureza:98%Forma y color:SolidPeso molecular:892.01Pralidoxime
CAS:Pralidoxime reactivates AChE blocked by nerve agents, aiding as an organophosphate poisoning antidote.Fórmula:C7H9N2OForma y color:SolidPeso molecular:137.16Amakusamine
CAS:Amakusamine is an indole alkaloid from the sponge of Psammocinia sp. that inhibits RANKL-induced isolation of multinucleated osteoclast formation.Fórmula:C9H5Br2NO2Pureza:98.37% - 98.42%Forma y color:SolidPeso molecular:318.95Rostratin A
CAS:Rostratin A, a disulfide from Exserohilum rostratum, is cytotoxic to HCT-116 cells with an IC50 of 8.5 μg/mL.Fórmula:C18H24N2O6S2Forma y color:SolidPeso molecular:428.52Rostratin B
CAS:Rostratin B, a cytotoxic disulfide, demonstrates in vitro cytotoxicity against human colon carcinoma (HCT-116), exhibiting an IC50 value of 1.9 μg/mL.Fórmula:C18H20N2O6S2Forma y color:SolidPeso molecular:424.49Rostratin C
CAS:Rostratin C, a cytotoxic disulfide, exhibits in vitro cytotoxicity against human colon carcinoma (HCT-116), demonstrating an IC50 value of 0.76 μg/mL.Fórmula:C20H24N2O8S2Forma y color:SolidPeso molecular:484.54Thielavin B
CAS:Thielavin B, from Thielavia terricola, inhibits prostaglandin E2 synthesis and reduces rat oedema.Fórmula:C31H34O10Forma y color:SolidPeso molecular:566.6Isodispar B
CAS:Isodispar B: an anticancer drug, halts many cancer types' growth, triggers cell death.Fórmula:C20H18O5Forma y color:SolidPeso molecular:338.35Mammea A/BA
CAS:Mammea A/BA combats T. cruzi by causing mitochondrial damage, ROS, DNA fragmentation, and vacuolization, leading to cell death. Useful for Chagas research.Fórmula:C25H26O5Forma y color:SolidPeso molecular:406.47Kurzipene D
CAS:Kurzipene D: anticancer, induces apoptosis, halts HepG2 at S phase, anti-tumor in zebrafish, inhibits tumor growth and spread.Fórmula:C26H36O8Forma y color:SolidPeso molecular:476.56Vorasidenib
CAS:Vorasidenib (PVM/MA) is an inhibitor of mutant isocitrate dehydrogenase (IDH; IC50s = 31.9 and 31.7 nM for IDH1R132H and IDH2R140Q, respectively)Fórmula:C14H13ClF6N6Pureza:98.28% - 99.57%Forma y color:SolidPeso molecular:414.74STAT3-IN-14
CAS:<p>STAT3-IN-14 is a STAT3 inhibitor and has STAT3 phosphorylation inhibitory activity. STAT3-IN-14 can directly bind to the hinge region of STAT3 .</p>Fórmula:C14H10O5Forma y color:SolidPeso molecular:258.23PTP1B-IN-20
PTP1B-IN-20: Selective PTP1B inhibitor, IC50=1.05μM; less effective on TCPTP (IC50=78μM), targets type 2 diabetes.Fórmula:C26H28O15Forma y color:SolidPeso molecular:580.49PTP1B-IN-21
PTP1B-IN-21 inhibits PTP1B (IC50=1.56μM) selectively over TCPTP, a type 2 diabetes target.Fórmula:C22H22O11Forma y color:SolidPeso molecular:462.4Phanginin A
CAS:Phanginin A, a natural product, activates SIK1 and inhibits gluconeogenesis in mouse primary hepatocytes, can be used in studies of type 2 diabetes.Fórmula:C21H28O5Pureza:95.54%Forma y color:SolidPeso molecular:360.44BACE1-IN-10
CAS:<p>BACE1-IN-10 is a potent inhibitor of BACE1, demonstrating sub-micromolar activity against recombinant BACE1 (rBACE1) [1].</p>Fórmula:C33H49N5O8SPureza:98%Forma y color:SolidPeso molecular:675.84Nomifensine
CAS:Nomifensine ((±)-Nomifensin) is a norepinephrine-dopamine reuptake inhibitor that prevents dopamine reuptake into synaptosomes.Fórmula:C16H18N2Pureza:99.83% - ≥95%Forma y color:SolidPeso molecular:238.33(R)-V-0219
(R)-V-0219: GLP-1R PAM, orally active, triggers Ca++ flux in HEK-hGLP-1R cells.Fórmula:C20H25F3N4O2Forma y color:SolidPeso molecular:410.43(S)-V-0219
(S)-V-0219: oral, GLP-1R PAM, boosts calcium in hGLP-1R HEK cells, lowers glucose, curbs hunger in mice.Fórmula:C20H25F3N4O2Forma y color:SolidPeso molecular:410.43TES Sodium
CAS:TES sodium is an amphoteric ion buffer with an effective pH range of 6.8 to 8.2, commonly used in cell culture and enzyme studies.Fórmula:C6H15NNaO6SForma y color:SolidPeso molecular:252.24Nipradolol
CAS:Nipradolol blocks alpha-1-adrenergic receptors, lowers IOP in rabbits, and reduces NA-induced muscle contraction and dog artery vasodilation.Fórmula:C15H22N2O6Forma y color:SolidPeso molecular:326.35BMS 310705
CAS:BMS 310705, an Epothilone B analog, targets ovarian/renal/bladder/lung cancer, inducing apoptosis via mitochondria.Fórmula:C27H42N2O6SForma y color:SolidPeso molecular:522.70Talotrexin
CAS:Talotrexin (PT523), a nonpolyglutamatable antifolate analog of Aminopterin, inhibits DHFR and RFC, targeting tumor growth.Fórmula:C27H27N9O6Forma y color:SolidPeso molecular:573.56Mavodelpar
CAS:Mavodelpar (REN001), a PPARδ agonist, may treat PMM and LC-FAOD by reducing renal damage.Fórmula:C31H29FNNaO5Forma y color:SolidPeso molecular:537.55TAS-103 dihydrochloride
CAS:<p>TAS-103 dihydrochloride (BMS-247615 dihydrochloride) is a novel anticancer agent targeting both topoisomerase (Topo) I and Topo II.</p>Fórmula:C20H21Cl2N3O2Pureza:97.78%Forma y color:SolidPeso molecular:406.31EphB1-IN-1
CAS:EphB1-IN-1 is a potent inhibitor of EphB1, exhibiting IC50 values of 3.0 nM for EphB1 G703C, 15 nM for EphB1 T697G, and 220 nM for EphB1 WT.Fórmula:C16H12Cl2N4O2Forma y color:SolidPeso molecular:363.2NBI-921352
CAS:NBI-921352 (XEN901) is a potent NaV1.6 sodium channel inhibitor, effectively treating epilepsy without severe side effects.Fórmula:C22H25FN4O2S2Pureza:98%Forma y color:SolidPeso molecular:460.59Udifitimod
CAS:Udifitimod (BMS-986166) is a potent, selective, and orally active modulator of the S1P1R receptor, showing potential for research in autoimmune diseases.Fórmula:C25H33NO2Forma y color:SolidPeso molecular:379.54Z-VRPR-FMK
CAS:Z-VRPR-FMK: irreversible MALT1 inhibitor, halts growth/invasion of diffused B-cell lymphoma by blocking NF-κB activation and MMP expression.Fórmula:C31H49FN10O6Forma y color:SolidPeso molecular:676.78Adhesamine
CAS:Adhesamine, a dumbbell molecule, enhances cell adhesion, growth, neuron differentiation, and survival via MAPK/FAK.Fórmula:C24H32Cl4N8O2S2Forma y color:SolidPeso molecular:670.51PNU-101603
CAS:<p>PNU-101603, a Sutezolid metabolite, effective against TB including drug-resistant strains, works solo or with SQ109.</p>Fórmula:C16H20FN3O4SForma y color:SolidPeso molecular:369.41Z-LEVD-FMK
CAS:Z-LEVD-FMK is a caspase-4 inhibitor with anti-cancer activity, capable of eliminating LPS-induced GCLC protein degradation.Fórmula:C31H45FN4O10Forma y color:SolidPeso molecular:652.71SID-852843
CAS:SID-852843, WNV NS2B-NS3 protease inhibitor, IC50: 0.105 μM, useful in viral infection studies.Fórmula:C17H15N3O5SPureza:99.59%Forma y color:SolidPeso molecular:373.38BACE2-IN-1
CAS:<p>BACE2-IN-1, a potent BACE2 inhibitor characterized by its exceptional selectivity and a Ki value of 1.6 nM, is utilized in the investigation of Type 2 Diabetes.</p>Fórmula:C36H38F3N3O3Forma y color:SolidPeso molecular:617.7Etbicyphat
CAS:Etbicyphat: potent GABA(A) antagonist, induces epileptiform activity, binds to GABA/benzodiazepine receptors.Fórmula:C6H11O4PForma y color:SolidPeso molecular:178.12Paquinimod
CAS:Paquinimod (ABR 25757) is a S100A9 inhibitor preventing S100A9 binding to TLR-4.Fórmula:C21H22N2O3Pureza:98.04% - 99.79%Forma y color:SolidPeso molecular:350.41ACT-606559
ACT-606559, a metabolite of ACT451840, is a novel chemical compound exhibiting antimalarial properties. It is utilized in malaria research.Fórmula:C47H52N6O3Forma y color:SolidPeso molecular:748.95EGFR-IN-25
CAS:EGFR-IN-25, an efficacious EGFR inhibitor, demonstrates IC50 values of 9 nM for BaF3 cells (EGFR DEL19/T790M/C797S) and 60 nM for A431 cells (WT), respectively.Fórmula:C34H43N9O2Forma y color:SolidPeso molecular:609.76EGFR-IN-21
CAS:EGFR-IN-21, a potent EGFR inhibitor, exhibits an IC50 of 0.38 nM, demonstrating significant antitumor activity.Fórmula:C36H44BrN10O2PForma y color:SolidPeso molecular:759.68EGFR-IN-23
CAS:EGFR-IN-23, identified as compound 8 in WO2021244502A1, is a potent EGFR tyrosine kinase inhibitor (TKI) demonstrating an inhibitory concentration (IC50) of 8.Fórmula:C36H44BrN10O3PForma y color:SolidPeso molecular:775.68EGFR-IN-28
CAS:EGFR-IN-28 is a potent EGFR inhibitor. EGFR-IN-28 has antitumor activity .Fórmula:C31H39BrN10O3SForma y color:SolidPeso molecular:711.68EGFR-IN-29
CAS:EGFR-IN-29 is a potent EGFR inhibitor.Fórmula:C36H46BrN8O2PForma y color:SolidPeso molecular:733.68RAD51-IN-4
CAS:RAD51-IN-4, a potent RAD51 inhibitor, may be useful in researching mitochondrial defect-related conditions.Fórmula:C31H34FN5O5S2Forma y color:SolidPeso molecular:639.76EGFR-IN-30
CAS:EGFR-IN-30 is an EGFR inhibitor (IC50: 1-10 nM, <1 nM WT/mutants) with potential in cancer research.Fórmula:C28H33BrN7O2PForma y color:SolidPeso molecular:610.49JNK-1-IN-1
CAS:JNK-1-IN-1 is an inhibitor specifically targeting JNK-1, also exhibiting inhibition of MKK7 with an IC50 value of 7.8μM.Fórmula:C24H22N6SForma y color:SolidPeso molecular:426.54Oxyphenisatin acetate
CAS:<p>Oxyphenisatin acetate inhibits the growth of the breast cancer cell lines MCF7, T47D, HS578T, and MDA-MB-468.</p>Fórmula:C24H19NO5Pureza:98% - 99.35%Forma y color:SolidPeso molecular:401.41PI3Ka-IN-5
CAS:PI3Ka-IN-5 is a potent PI3Kα/mTOR inhibitor, with an IC 50 of 0.7 nM and 3.3 nM, respectively. PI3Ka-IN-5 can be used for the research of colorectal cancer .Fórmula:C30H35N9O5Forma y color:SolidPeso molecular:601.66IDO1-IN-17
CAS:IDO1-IN-17 (I-4) is an IDO1 inhibitor, with an IC 50 of 0.44 μM in hela cells .Fórmula:C28H32BrClFN5O2Forma y color:SolidPeso molecular:604.94STAT3-IN-7
CAS:STAT3-IN-7, an orally active aryl sulfonamido azetidine compound, serves as a STAT3 inhibitor with anticancer activities.Fórmula:C30H26F5N5O4SForma y color:SolidPeso molecular:647.62(S)-HH2853
CAS:(S)-HH2853 is a potent EZH1/2 inhibitor, aromatic, <100 nM IC50 for EZH2_Y641F, promising for anti-tumor/autoimmune research.Fórmula:C31H36F3N7O3Pureza:97.18% - 99.74%Forma y color:SolidPeso molecular:611.66(R)-HH2853
CAS:(R)-HH2853, a mutant EZH2 inhibitor, IC50 <100 nM for EZH2-Y641F, targets cancer/autoimmune diseases.Fórmula:C31H36F3N7O3Pureza:97.53% - 98.85%Forma y color:SolidPeso molecular:611.66ROCK2-IN-5
ROCK2-IN-5, a compound blending fasudil, caffeic, and ferulic acids, shows promise for ALS research involving SOD1 mutations.Fórmula:C23H25N3O5SForma y color:SolidPeso molecular:455.53PI3K-IN-28
CAS:PI3K-IN-28, a potent PI3K inhibitor with low toxicity in MCF-10a, has IC50 values of 5.8, 2.3, 7.9 μM and high selectivity index of 39.Fórmula:C26H16F9N3O3S2Forma y color:SolidPeso molecular:653.54AX20017
CAS:<p>AX20017 is a small-molecule protein kinase G (PknG) inhibitor(IC50 : 0.39 μM). It acts by blocking the proliferation of M. tuberculosis.</p>Fórmula:C13H16N2O2SPureza:99.31%Forma y color:SolidPeso molecular:264.34MptpB-IN-1
CAS:MptpB-IN-1: orally active, potent MptpB inhibitor; reduces drug-resistant tuberculosis.Fórmula:C17H11Cl2NO4Forma y color:SolidPeso molecular:364.18FGFR4-IN-8
CAS:FGFR4-IN-8 is a selective, ATP-competitive FGFR4 inhibitor with IC50s as low as 0.25 nM, halting growth of Hep3B cells at 29 nM and showing in vivo efficacy.Fórmula:C32H34Cl2FN7O3Pureza:98%Forma y color:SolidPeso molecular:654.56ThrRS-IN-3
ThrRS-IN-3: Potent inhibitor of Salmonella enterica ThrRS, IC50 = 19 nM, Kd = 34 nM, with antibacterial effects.Fórmula:C31H30Cl2N6O5Forma y color:SolidPeso molecular:637.51SMTIN-T140
CAS:SMTIN-T140: strong TRAP1 inhibitor, IC50=1.646μM, anticancer; disrupts mitochondria, boosts ROS, activates AMPK, shrinks PC3 tumors, no in vivo toxicity.Fórmula:C36H34BrClFN5OPPureza:98%Forma y color:SolidPeso molecular:718.02C16-K-cBB1
C16-K-cBB1: potent, selective MRSA killer; MIC 1µg/mL, low hemolysis, works in 120 min at 12.5µg/mL.Fórmula:C33H58ClN5O5SForma y color:SolidPeso molecular:672.36EGFR-IN-61
CAS:EGFR-IN-61 inhibits EGFR kinase (IC50: 42 nM L858R/T790M, 137 nM L858R/T790M/C797S, 743 nM WT) and slows A549 & H1975 cell growth (IC50: 2.14 & 1.82 μM).Fórmula:C33H37ClN8O3Pureza:98%Forma y color:SolidPeso molecular:629.15STAT6-IN-1
CAS:STAT6-IN-1: STAT6 inhibitor, IC50=0.028 µM, targets SH2 domain, for allergy and cancer research.Fórmula:C33H37IN3O7PForma y color:SolidPeso molecular:745.54Enclomiphene citrate
CAS:Enclomiphene citrate (trans-Clomiphene citrate) is a non-steroidal estrogen receptor antagonist,with antioestrogenic propertyFórmula:C32H36ClNO8Pureza:99.95%Forma y color:SolidPeso molecular:598.08Mebanazine
CAS:<p>Mebanazine, a potent monoamine oxidase (MAO) inhibitor, is utilized in depression research.</p>Fórmula:C8H12N2Forma y color:SolidPeso molecular:136.19DS69910557
DS69910557: potent hPTHR1 antagonist, IC50 0.08 μM, oral, for hyperparathyroidism & osteoporosis research.Fórmula:C32H33Cl2FN4O3Forma y color:SolidPeso molecular:611.53FGF22-IN-1
CAS:<p>FGF22-IN-1 is a CD4 N-terminal immunoglobulin variable region-like structural domain (CD4 D1) inhibitor that suppresses the immune response.</p>Fórmula:C14H11N3OSPureza:99.18%Forma y color:SolidPeso molecular:269.32EZH2-IN-14
CAS:<p>EZH2-IN-14 selectively inhibits EZH2 at 12 nM IC50, has >200-fold specificity over EZH1, reducing H3K27me3 levels.</p>Fórmula:C31H39N7O2Forma y color:SolidPeso molecular:541.69USP7-IN-10
CAS:<p>USP7-IN-10 is a potent inhibitor of ubiquitin-specific protease 7 (USP7), exhibiting an inhibition concentration half-maximal (IC50) value of 13.39 nM.</p>Fórmula:C26H29ClN4O3SForma y color:SolidPeso molecular:513.05MAT2A-IN-9
CAS:<p>MAT2A-IN-9, a 2-oxoquinazoline, inhibits MAT2A with antitumor effects on lymphomas and solid cancers.</p>Fórmula:C14H8ClF3N4OPureza:99.17%Forma y color:SolidPeso molecular:340.69GSK1790627
CAS:GSK1790627, the N-deacetylated metabolite of Trametinib, represents an orally active MEK inhibitor that promotes autophagy and triggers apoptosis [1].Fórmula:C24H21FIN5O3Forma y color:SolidPeso molecular:573.36FLT3-IN-18
CAS:FLT3-IN-18: potent, selective FLT3 inhibitor, IC50 0.003 μM, induces apoptosis, G1 arrest, blocks FLT3/STAT5, potential in AML research.Fórmula:C26H36N8OForma y color:SolidPeso molecular:476.62PHGDH-IN-3
CAS:PHGDH-IN-3, an oral PHGDH blocker with 2.8 μM IC50, may help in cancer research.Fórmula:C24H18FN3O4S2Pureza:97.24% - 99.1%Forma y color:SolidPeso molecular:495.55FGFR3-IN-4
CAS:FGFR3-IN-4 is a selective inhibitor targeting FGFR3, demonstrating an IC50 value of under 50 nM.Fórmula:C26H24ClN7OForma y color:SolidPeso molecular:485.97FGFR3-IN-5
CAS:<p>FGFR3-IN-5: potent, selective FGFR3 inhibitor. IC50: 3 nM FGFR3, 44 nM FGFR2, 289 nM FGFR1. For cancer research.</p>Fórmula:C24H24FN7O3Forma y color:SolidPeso molecular:477.49ACT-777991
CAS:ACT-777991: oral CXCR3 blocker, stable in microsomes/hepatocytes, inhibits T-cell migration to CXCL11.Fórmula:C20H20F6N8O2SForma y color:SolidPeso molecular:550.48HPK1-IN-33
CAS:HPK1-IN-33 inhibits HPK1 with 1.7 nM potency, reduces IL-2 in Jurkat cells with 286 nM EC50, and is less effective in HPK1 KO cells.Fórmula:C18H16ClFN6Forma y color:SolidPeso molecular:370.81
